| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 19 | 2025 | 214 | 8.310 |
Why?
|
| Hyperoxia | 19 | 2025 | 135 | 6.340 |
Why?
|
| Lung | 24 | 2025 | 1565 | 4.560 |
Why?
|
| Receptors, Aryl Hydrocarbon | 10 | 2022 | 70 | 4.410 |
Why?
|
| Hypertension, Pulmonary | 11 | 2025 | 463 | 4.100 |
Why?
|
| Adrenomedullin | 6 | 2025 | 82 | 3.820 |
Why?
|
| Lipopolysaccharides | 6 | 2024 | 300 | 2.250 |
Why?
|
| Omeprazole | 5 | 2016 | 100 | 2.060 |
Why?
|
| Endothelial Cells | 7 | 2020 | 536 | 1.860 |
Why?
|
| Pulmonary Alveoli | 6 | 2024 | 138 | 1.410 |
Why?
|
| Animals, Newborn | 14 | 2025 | 1024 | 1.400 |
Why?
|
| Disease Models, Animal | 11 | 2025 | 4683 | 1.190 |
Why?
|
| Cytochrome P-450 CYP1A1 | 5 | 2017 | 82 | 1.180 |
Why?
|
| Acute Lung Injury | 3 | 2022 | 67 | 1.120 |
Why?
|
| Signal Transduction | 7 | 2024 | 4666 | 1.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2017 | 26 | 0.980 |
Why?
|
| Isoxazoles | 2 | 2017 | 32 | 0.980 |
Why?
|
| Infant, Premature | 7 | 2024 | 854 | 0.970 |
Why?
|
| Mice, Inbred C57BL | 15 | 2024 | 4761 | 0.950 |
Why?
|
| Pulmonary Circulation | 2 | 2017 | 114 | 0.950 |
Why?
|
| Cell Proliferation | 5 | 2024 | 2464 | 0.920 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2016 | 131 | 0.890 |
Why?
|
| Oxidative Stress | 7 | 2018 | 804 | 0.830 |
Why?
|
| Interleukin-17 | 1 | 2024 | 128 | 0.820 |
Why?
|
| Pneumonia | 4 | 2024 | 344 | 0.800 |
Why?
|
| Vascular Remodeling | 2 | 2020 | 50 | 0.770 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2020 | 106 | 0.760 |
Why?
|
| Proton Pump Inhibitors | 2 | 2015 | 278 | 0.750 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 651 | 0.750 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2024 | 430 | 0.720 |
Why?
|
| Fetus | 4 | 2018 | 585 | 0.700 |
Why?
|
| Animals | 24 | 2025 | 34321 | 0.690 |
Why?
|
| Mice | 17 | 2025 | 18464 | 0.680 |
Why?
|
| Receptor, TIE-2 | 1 | 2020 | 13 | 0.650 |
Why?
|
| Transcriptome | 4 | 2024 | 1162 | 0.640 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 305 | 0.640 |
Why?
|
| Hydrogen Peroxide | 2 | 2018 | 117 | 0.620 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 187 | 0.600 |
Why?
|
| Integrases | 1 | 2020 | 158 | 0.590 |
Why?
|
| Infant, Newborn | 15 | 2024 | 8584 | 0.570 |
Why?
|
| Catalase | 1 | 2018 | 64 | 0.570 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2015 | 49 | 0.570 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 173 | 0.540 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2017 | 16 | 0.530 |
Why?
|
| Lung Injury | 5 | 2020 | 123 | 0.520 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 80 | 0.520 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 204 | 0.510 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 34 | 0.500 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2016 | 16 | 0.500 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 234 | 0.500 |
Why?
|
| Proteome | 1 | 2018 | 286 | 0.490 |
Why?
|
| Microvessels | 1 | 2016 | 65 | 0.480 |
Why?
|
| Immunologic Factors | 1 | 2017 | 192 | 0.460 |
Why?
|
| Transcription Factor RelB | 1 | 2015 | 4 | 0.460 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 259 | 0.460 |
Why?
|
| Capillaries | 1 | 2015 | 67 | 0.450 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 96 | 0.440 |
Why?
|
| Cells, Cultured | 5 | 2018 | 2970 | 0.430 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 501 | 0.430 |
Why?
|
| Up-Regulation | 1 | 2017 | 832 | 0.430 |
Why?
|
| Vasopressins | 1 | 2013 | 44 | 0.390 |
Why?
|
| Heart | 1 | 2017 | 674 | 0.390 |
Why?
|
| Cell Survival | 4 | 2018 | 853 | 0.390 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 441 | 0.380 |
Why?
|
| Antioxidants | 1 | 2015 | 336 | 0.380 |
Why?
|
| Smoking | 1 | 2017 | 926 | 0.370 |
Why?
|
| Humans | 29 | 2025 | 131410 | 0.370 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 135 | 0.370 |
Why?
|
| Biomarkers | 3 | 2020 | 3400 | 0.370 |
Why?
|
| Hypotension | 1 | 2013 | 184 | 0.340 |
Why?
|
| Liver | 3 | 2015 | 1794 | 0.340 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 112 | 0.330 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 1624 | 0.310 |
Why?
|
| Oxygen | 1 | 2013 | 552 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2020 | 88 | 0.300 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1831 | 0.290 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 302 | 0.290 |
Why?
|
| Time Factors | 4 | 2024 | 6272 | 0.290 |
Why?
|
| Apoptosis | 3 | 2024 | 1862 | 0.290 |
Why?
|
| Actins | 2 | 2024 | 317 | 0.290 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 566 | 0.280 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 2354 | 0.280 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 2363 | 0.280 |
Why?
|
| Inflammation | 4 | 2022 | 1488 | 0.270 |
Why?
|
| Epithelial Cells | 1 | 2011 | 900 | 0.260 |
Why?
|
| Gestational Age | 2 | 2023 | 1220 | 0.250 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3860 | 0.240 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2018 | 145 | 0.240 |
Why?
|
| Organ Size | 3 | 2017 | 434 | 0.230 |
Why?
|
| Feasibility Studies | 3 | 2017 | 827 | 0.230 |
Why?
|
| Microbiota | 2 | 2022 | 441 | 0.220 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 469 | 0.220 |
Why?
|
| Phenyl Ethers | 1 | 2024 | 12 | 0.210 |
Why?
|
| Infant, Premature, Diseases | 2 | 2024 | 255 | 0.210 |
Why?
|
| Apnea | 1 | 2024 | 28 | 0.210 |
Why?
|
| Female | 13 | 2021 | 71030 | 0.200 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 106 | 0.200 |
Why?
|
| Pregnancy | 6 | 2021 | 7571 | 0.200 |
Why?
|
| Random Allocation | 2 | 2015 | 421 | 0.200 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 665 | 0.200 |
Why?
|
| Vascular Resistance | 1 | 2023 | 182 | 0.190 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 55 | 0.190 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 344 | 0.180 |
Why?
|
| Gene Dosage | 2 | 2021 | 439 | 0.180 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 97 | 0.180 |
Why?
|
| Dysbiosis | 2 | 2022 | 146 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 420 | 0.170 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 114 | 0.170 |
Why?
|
| Ligands | 1 | 2022 | 486 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 518 | 0.160 |
Why?
|
| Receptor Activity-Modifying Protein 2 | 1 | 2020 | 12 | 0.160 |
Why?
|
| Malondialdehyde | 2 | 2016 | 49 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 387 | 0.150 |
Why?
|
| Male | 9 | 2020 | 65108 | 0.150 |
Why?
|
| Neutrophil Infiltration | 3 | 2015 | 65 | 0.140 |
Why?
|
| Alprostadil | 1 | 2018 | 22 | 0.140 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2017 | 1 | 0.140 |
Why?
|
| Respiratory System | 1 | 2018 | 97 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2017 | 20 | 0.140 |
Why?
|
| Chorioamnionitis | 1 | 2017 | 44 | 0.130 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2017 | 41 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 326 | 0.130 |
Why?
|
| Neonatal Sepsis | 1 | 2017 | 40 | 0.130 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 547 | 0.130 |
Why?
|
| Perinatal Care | 1 | 2017 | 67 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 579 | 0.130 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2017 | 76 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 201 | 0.120 |
Why?
|
| Infant, Extremely Premature | 1 | 2017 | 112 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 91 | 0.120 |
Why?
|
| Databases, Genetic | 2 | 2016 | 500 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme Inducers | 1 | 2015 | 2 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2020 | 781 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2018 | 600 | 0.120 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 66 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 107 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 232 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2017 | 528 | 0.110 |
Why?
|
| Anti-Ulcer Agents | 1 | 2015 | 114 | 0.110 |
Why?
|
| Infant Care | 1 | 2005 | 46 | 0.110 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 192 | 0.110 |
Why?
|
| Cell Death | 1 | 2015 | 237 | 0.110 |
Why?
|
| Necrosis | 1 | 2015 | 194 | 0.110 |
Why?
|
| RNA Interference | 1 | 2016 | 496 | 0.110 |
Why?
|
| Benzo(a)pyrene | 1 | 2014 | 24 | 0.110 |
Why?
|
| Transfection | 1 | 2016 | 960 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 382 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2017 | 773 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 530 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 380 | 0.100 |
Why?
|
| Lypressin | 1 | 2013 | 18 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2014 | 1018 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 1008 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2015 | 414 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 135 | 0.100 |
Why?
|
| Myocardium | 1 | 2017 | 874 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 483 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 642 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2016 | 816 | 0.090 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2013 | 84 | 0.090 |
Why?
|
| Echocardiography | 1 | 2017 | 1138 | 0.090 |
Why?
|
| Cytoprotection | 1 | 2011 | 37 | 0.090 |
Why?
|
| Microsomes | 1 | 2011 | 37 | 0.090 |
Why?
|
| Enzyme Induction | 1 | 2011 | 97 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 297 | 0.080 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 56 | 0.080 |
Why?
|
| Computational Biology | 1 | 2016 | 872 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1001 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 371 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2297 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2204 | 0.080 |
Why?
|
| Incidence | 1 | 2017 | 3340 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2568 | 0.080 |
Why?
|
| Infant | 2 | 2023 | 13292 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1236 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1610 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3411 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3909 | 0.060 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 90 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2024 | 24 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 3671 | 0.050 |
Why?
|
| Osteomalacia | 1 | 2003 | 7 | 0.050 |
Why?
|
| Rickets | 1 | 2003 | 7 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10947 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2024 | 262 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 463 | 0.040 |
Why?
|
| Metabolome | 1 | 2022 | 329 | 0.040 |
Why?
|
| Mutation | 1 | 2013 | 6177 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 231 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 615 | 0.030 |
Why?
|
| Dinoprost | 1 | 2015 | 25 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 20 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 28 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2142 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 248 | 0.030 |
Why?
|
| India | 1 | 2005 | 245 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2014 | 30 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 99 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 170 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2014 | 71 | 0.030 |
Why?
|
| Adult | 1 | 2015 | 31628 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 82 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2005 | 233 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2013 | 200 | 0.020 |
Why?
|
| Neutrophils | 1 | 2015 | 370 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 595 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1069 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 986 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 501 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2563 | 0.020 |
Why?
|
| Length of Stay | 1 | 2005 | 1393 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3613 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3454 | 0.020 |
Why?
|